Concepedia

Author

Pierre Stryckmans

Institut Jules Bordet

Also Known As

A. Jacobs, EORTC Leukemia Group, P A Stryckmans, P Stryckmans, P. A. STRYCKMANS, P. A. Stryckmans, P. STRYCKMANS, P. Stryckmans, P.A. Stryckmans, PIERRE A. STRYCKMANS

149

Publications

4.3K

Citations

31

H-Index

76

Concepts

All Affiliations

Institut Jules BordetUniversité Libre de BruxellesBrookhaven National LaboratoryHôtel-Dieu de ParisEuropean Organisation for Research and Treatment of Cancer
PS

About

Pierre Stryckmans is an author at Institut Jules Bordet specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

30

949

2

Health Sciences

10

11

246

3

Engineering

1

1

33

4

Natural Sciences

1

1

21

5

Nursing

1

1

25

Pierre Stryckmans

×

61

Publications

3.9K

Citations

29

H-Index

YearCitations

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

R Zittoun, Franco Mandelli, Roel Willemze,

New England Journal of Medicine

1995

853

Chronic Lymphocytic Leukemic B Cells But Not Normal B Cells Are Rescued From Apoptosis by Contact With Normal Bone Marrow Stromal Cells

Laurence Lagneaux, A. Delforge, Dominique Bron,

Blood

1998

392

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud,

Journal of Clinical Oncology

1998

288

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud,

PubMed

1997

206

Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia

M Sarfati, Sylvie Chevret, Claude Chastang,

Blood

1996

192

Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

R Zittoun, Stefan Suciu, Franco Mandelli,

Journal of Clinical Oncology

1996

122

Deoxyribonucleic Acid Synthesis Time of Erythropoietic and Granulopoietic Cells in Human Beings

Pierre Stryckmans, E.P. Cronkite, J. FACHE,

Nature

1966

99

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893).

Roel Willemze, Stefan Suciu, E Archimbaud,

PubMed

1997

88

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial.

Boris Labar, Stefan Suciu, R Zittoun,

PubMed

2004

87

Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.

Anthony D. Ho, J. Thaler, Franco Mandelli,

Journal of Clinical Oncology

1989

69

Page 1